Edition:
India

Xvivo Perfusion Q1 Adjusted EBITDA Up At SEK 8.8 Mln


Wednesday, 24 Apr 2019 

April 24 (Reuters) - Xvivo Perfusion AB ::STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE RESEARCH AND DEVELOPMENT PORTFOLIO.Q1 NET SALES SEK 47.7 MILLION VERSUS SEK 42.5 MILLION YEAR AGO.Q1 ADJ EBITDA SEK 8.8 MLN VS SEK 7.2 MLN YR AGO. 

Company Quote

183.0
-6.0 -3.17%
24 May 2019